COLON CARCINOMA
Clinical trials for COLON CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new COLON CARCINOMA trials appear
Sign up with your email to follow new studies for COLON CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy before colon surgery shows promise in early cancer trial
Disease control Recruiting nowThis study is for people with stage 1-3 colon cancer that hasn't spread. Participants receive a short course of immunotherapy (nivolumab, ipilimumab, and other drugs) for 6-12 weeks before their tumor is surgically removed. The goal is to see if this approach is safe and can shri…
Matched conditions: COLON CARCINOMA
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Jun 16, 2026 22:51 UTC
-
Promising antibody drug targets Hard-to-Treat colorectal cancer before surgery
Disease control Recruiting nowThis study tests a drug called zanidatamab, given before surgery, for people with HER2-positive colorectal cancer. The drug is a lab-made antibody that helps stop cancer cells from growing. About 38 participants will receive the treatment to see if it shrinks tumors and improves …
Matched conditions: COLON CARCINOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 16, 2026 22:50 UTC
-
Can cannabis calm chemo nerve pain? new study seeks answers
Symptom relief Recruiting nowThis study tests whether compounds from cannabis (CBD and THC) can reduce chronic nerve pain, tingling, and numbness caused by chemotherapy in breast and colon cancer survivors. About 120 people will take part and report their symptoms over 12 weeks. The goal is to find a better …
Matched conditions: COLON CARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 15, 2026 19:02 UTC
-
New algorithm aims to keep chemo on schedule for GI cancer patients
Symptom relief Recruiting nowThis study tests a tool called PAGODA that helps doctors adjust chemotherapy doses to avoid unplanned treatment delays. About 420 people with gastrointestinal cancers will be randomly assigned to use the algorithm or receive usual care. The goal is to see if the algorithm reduces…
Matched conditions: COLON CARCINOMA
Phase: NA • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Symptom relief
Last updated Jun 15, 2026 18:54 UTC
-
New imaging tracer lights up tumors in first human tests
Knowledge-focused Recruiting nowThis early-phase study is testing a new radioactive imaging agent in 32 adults with various solid tumors. The goal is to see how the agent spreads through the body and whether it can highlight tumors on PET/CT scans. Participants receive a single injection of the agent and underg…
Matched conditions: COLON CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Var2 Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC